Marketing-authorisation holder · United States
Par Pharm
17 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
17 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
17 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANTIZOL1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Fomepizole | United States | Not marketed | 1997 |
| CHLORPROPAMIDE100mg | 250mg · Tablet | Chlorpropamide | United States | Not marketed | 1980 |
| CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE15mg; 0.1mg | 15mg; 0.2mg | 15mg; 0.3mg · Tablet | Chlorthalidone, Clonidine | United States | Not marketed | 1987 |
| DOXY-SLEEP-AID25mg · Tablet | Doxylamine | United States | Not marketed | |
| FENTANYL CITRATE0.2mg base | 0.4mg base | 0.6mg base | 0.8mg base | 1.2mg base | 1.6mg base · Troche/lozenge | Fentanyl | United States | Not marketed | 2009 |
| HYDRO-RIDE5mg anhydrous; 50mg · Tablet | Amiloride, Hydrochlorothiazide | United States | Not marketed | 1986 |
| MEPROBAMATE AND ASPIRIN325mg; 200mg · Tablet | Acetylsalicylic acid, Meprobamate | United States | Not marketed | |
| METHYLDOPA AND CHLOROTHIAZIDE150mg; 250mg | 250mg; 250mg · Tablet | Chlorothiazide, Methyldopa | United States | Not marketed | |
| MILNACIPRAN HYDROCHLORIDE100mg | 12.5mg | 25mg | 50mg · Tablet | Milnacipran | United States | Marketed | 2015 |
| TRICHLORMETHIAZIDE2mg | 4mg · Tablet | Trichlormethiazide | United States | Not marketed | 1977 |
| VARDENAFIL HYDROCHLORIDE10mg · Tablet, orally disintegrating | Vardenafil | United States | Marketed | 2016 |
| CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE12gm/packet; 3.5gm/packet; 10mg/packet · For solution | Citric acid, Magnesium oxide, Picosulfate | United States | tentative | 2016 |
| FINGOLIMOD0.5mg | 0.5mg base · Capsule | Fingolimod | United States | tentative | 2017 |
| LATANOPROST0.005% · Solution | Latanoprost | United States | tentative | 2007 |
| SAXAGLIPTIN5MG · Tablet | Saxagliptin | United States | tentative | 2016 |
| SUMATRIPTAN; NAPROXEN SODIUM85mg; 500mg · Tablet | Sumatriptan, Naproxen | United States | tentative | 2011 |
| TRAVOPROST0.004% · Solution | Travoprost | United States | tentative | 2011 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 17 | 11 | 6 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.